Premier Partners provides integrated solutions to streamline and advance drug development programs for emerging biotech companies. Contact us to learn how Premier Partners can optimize and execute your nonclinical & early clinical programs.
Serving as an integrated extension of your team, Premier Partners helps you reach critical milestones faster. We provide study design, nonclinical laboratory selection, and program management solutions to drive a seamless transition into the clinic – and beyond. Our collaborative, proactive approach manages regulatory risks and keeps your timeline on track.
Key benefits:
Learn how you can work with Premier Partners to achieve success.
This white paper offers insight into nonclinical study requirements and recommendations for putting together an optimal nonclinical team.
This guide explains why successful nonclinical strategies leverage smart design and planning to minimize risk in critical early-stage milestones.
In this webinar, our experts discuss how to prepare for conducting and managing IND-enabling nonclinical studies while meeting FDA guidelines.
Our experienced team of drug development experts is committed to using your research goals to plan effective early development programs. We provide strategy, study design, nonclinical laboratory selection, and program management solutions to execute a full range of GLP and non-GLP preclinical evaluation studies and advance your program into the clinic.
Transition into the clinic and set your sights on moving to and through proof of concept with CMC and early clinical support.
Our team brings diverse scientific and drug development expertise in areas including ADME/PK, bioanalysis, CMC, pharmacology, toxicology, and early clinical development. We collaborate with Premier Consulting’s Development Strategists to streamline and advance drug programs, while leveraging Premier Consulting’s Quality Management support capabilities to stay at the forefront of quality and compliance standards. We can support both non-regulated exploratory studies as well as regulated studies following GLP, GMP or GCP. The compounds and studies we support include:
